Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chemotherapy-Induced Neutropenia Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chemotherapy-Induced Neutropenia Treatment market segmented into
Antibiotic Therapy
Colony-Stimulating Factor Therapy
Granulocyte Transfusion
Splenectomy Procedure
Others
Based on the end-use, the global Chemotherapy-Induced Neutropenia Treatment market classified into
Hospitals
Ambulatory Surgical Center
Diagnostic Centers
Based on geography, the global Chemotherapy-Induced Neutropenia Treatment market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Amgen
Sanofi
Novartis AG
Baxter International
Teva Pharmaceuticals Industries
Apotex
Dr. Reddy s Laboratory
Biogenomics Limited
Ligand Pharmaceuticals
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHEMOTHERAPY-INDUCED NEUTROPENIA TREATMENT INDUSTRY
2.1 Summary about Chemotherapy-Induced Neutropenia Treatment Industry
2.2 Chemotherapy-Induced Neutropenia Treatment Market Trends
2.2.1 Chemotherapy-Induced Neutropenia Treatment Production & Consumption Trends
2.2.2 Chemotherapy-Induced Neutropenia Treatment Demand Structure Trends
2.3 Chemotherapy-Induced Neutropenia Treatment Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Antibiotic Therapy
4.2.2 Colony-Stimulating Factor Therapy
4.2.3 Granulocyte Transfusion
4.2.4 Splenectomy Procedure
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Ambulatory Surgical Center
4.3.3 Diagnostic Centers
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Antibiotic Therapy
5.2.2 Colony-Stimulating Factor Therapy
5.2.3 Granulocyte Transfusion
5.2.4 Splenectomy Procedure
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Center
5.3.3 Diagnostic Centers
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Antibiotic Therapy
6.2.2 Colony-Stimulating Factor Therapy
6.2.3 Granulocyte Transfusion
6.2.4 Splenectomy Procedure
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Ambulatory Surgical Center
6.3.3 Diagnostic Centers
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Antibiotic Therapy
7.2.2 Colony-Stimulating Factor Therapy
7.2.3 Granulocyte Transfusion
7.2.4 Splenectomy Procedure
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Ambulatory Surgical Center
7.3.3 Diagnostic Centers
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Antibiotic Therapy
8.2.2 Colony-Stimulating Factor Therapy
8.2.3 Granulocyte Transfusion
8.2.4 Splenectomy Procedure
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Ambulatory Surgical Center
8.3.3 Diagnostic Centers
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Antibiotic Therapy
9.2.2 Colony-Stimulating Factor Therapy
9.2.3 Granulocyte Transfusion
9.2.4 Splenectomy Procedure
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Ambulatory Surgical Center
9.3.3 Diagnostic Centers
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Amgen
10.1.2 Sanofi
10.1.3 Novartis AG
10.1.4 Baxter International
10.1.5 Teva Pharmaceuticals Industries
10.1.6 Apotex
10.1.7 Dr. Reddy s Laboratory
10.1.8 Biogenomics Limited
10.1.9 Ligand Pharmaceuticals
10.2 Chemotherapy-Induced Neutropenia Treatment Sales Date of Major Players (2017-2020e)
10.2.1 Amgen
10.2.2 Sanofi
10.2.3 Novartis AG
10.2.4 Baxter International
10.2.5 Teva Pharmaceuticals Industries
10.2.6 Apotex
10.2.7 Dr. Reddy s Laboratory
10.2.8 Biogenomics Limited
10.2.9 Ligand Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Chemotherapy-Induced Neutropenia Treatment Product Type Overview
Table Chemotherapy-Induced Neutropenia Treatment Product Type Market Share List
Table Chemotherapy-Induced Neutropenia Treatment Product Type of Major Players
Table Brief Introduction of Amgen
Table Brief Introduction of Sanofi
Table Brief Introduction of Novartis AG
Table Brief Introduction of Baxter International
Table Brief Introduction of Teva Pharmaceuticals Industries
Table Brief Introduction of Apotex
Table Brief Introduction of Dr. Reddy s Laboratory
Table Brief Introduction of Biogenomics Limited
Table Brief Introduction of Ligand Pharmaceuticals
Table Products & Services of Amgen
Table Products & Services of Sanofi
Table Products & Services of Novartis AG
Table Products & Services of Baxter International
Table Products & Services of Teva Pharmaceuticals Industries
Table Products & Services of Apotex
Table Products & Services of Dr. Reddy s Laboratory
Table Products & Services of Biogenomics Limited
Table Products & Services of Ligand Pharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chemotherapy-Induced Neutropenia Treatment Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chemotherapy-Induced Neutropenia Treatment Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chemotherapy-Induced Neutropenia Treatment Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chemotherapy-Induced Neutropenia Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Chemotherapy-Induced Neutropenia Treatment Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chemotherapy-Induced Neutropenia Treatment Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Antibiotic Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colony-Stimulating Factor Therapy Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Granulocyte Transfusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Splenectomy Procedure Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Ambulatory Surgical Center Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Diagnostic Centers Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Amgen 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Novartis AG 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Baxter International 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Teva Pharmaceuticals Industries 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Apotex 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Dr. Reddy s Laboratory 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Biogenomics Limited 2017-2020e
Figure Chemotherapy-Induced Neutropenia Treatment Sales Revenue (Million USD) of Ligand Pharmaceuticals 2017-2020e